Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).

about

TP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives.Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma

P2860

Q31103785-A532933F-B7FE-465B-8F4B-C711B4855165 Q52379412-1D413D4A-2898-4EC6-948A-8BD73091D369 Q58700294-81D83F14-E9F5-4923-8075-5E5F10B91131

P2860

Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).

Item

http://www.wikidata.org/entity/Q38741116

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeted therapy of osteosarco ...... wth factor-2 receptor (IGF2R).

@en

type

Item

label

Targeted therapy of osteosarco ...... wth factor-2 receptor (IGF2R).

@en

prefLabel

Targeted therapy of osteosarco ...... wth factor-2 receptor (IGF2R).

@en

P1476

Targeted therapy of osteosarco ...... wth factor-2 receptor (IGF2R).

@en

P2093

Amy Park

http://www.w3.org/2001/XMLSchema#string

Bang Hoang

http://www.w3.org/2001/XMLSchema#string

David S Geller

http://www.w3.org/2001/XMLSchema#string

Ekaterina Dadachova

http://www.w3.org/2001/XMLSchema#string

Ekaterina Revskaya

http://www.w3.org/2001/XMLSchema#string

Hillary Guzik

http://www.w3.org/2001/XMLSchema#string

Jonathan Gill

http://www.w3.org/2001/XMLSchema#string

Jonathan Morris

http://www.w3.org/2001/XMLSchema#string

Mani Kahn

http://www.w3.org/2001/XMLSchema#string

Michael Roth

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of childhood cancer

Antibody-targeted radiation cancer therapy

Alpha emitter radium-223 and survival in metastatic prostate cancer

Treating cancer as an infectious disease--viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

A systematic review of the role of pulmonary irradiation in the management of primary bone tumours.

International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.

P304

812-817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NUCMEDBIO.2016.07.008

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard G Gorlick

Charles B. Hall

P577

2016-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27744117

http://www.w3.org/2001/XMLSchema#string

P932

5118104

http://www.w3.org/2001/XMLSchema#string

Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).

about

P2860

P2860

Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932